Key License Agreements has the meaning set forth in Section 9.2(a).
Key License Agreements means, collectively, (i) the License Agreement dated December 23, 2002 by and among SCR Pharmatop S.A. and Xxxxxxx-Xxxxx Squibb Company; (ii) the IV APAP Agreement (U.S. and Canada) dated February 21, 2006 by and between the Company and Xxxxxxx-Xxxxx Squibb Company; (iii) the License Agreement dated November 27, 2012 by and between the Company and SCR Pharmatop S.A. and Paddock Laboratories, LLC and Xxxxxxx Company; (iv) the Settlement Agreement dated November 27, 2012 by and between the Company and SCR Pharmatop S.A. and Paddock Laboratories, LLC and Xxxxxxx Company; and (v) the settlement agreement and binding term sheet, each dated January 28, 2014, among the Company, Sandoz, Inc., Sandoz AG, Neogen International N.V. and APC Pharmaceuticals, LLC.
Key License Agreements means that certain License Agreement, dated July 29, 2014, between Durata Therapeutics International B.V. and A.C.R.A.F. S.p.A.
Examples of Key License Agreements in a sentence
From the date hereof through and following the Closing, Seller shall continue to perform its obligations under the Key License Agreements.
For the avoidance of doubt, as provided in Section 5.3.5(b), Novartis and its Affiliates, and their respective sublicensees, will comply with the applicable terms of the Key License Agreements[***].
Seller does not have any obligation to compensate any person for the use of any such Proprietary Rights nor has Seller granted to any person any license, option or other rights to use in any manner any of its Proprietary Rights, whether requiring the payment of royalties or not, except as set forth in the Key License Agreements or in Schedule 4.19(b).
More Definitions of Key License Agreements
Key License Agreements means the License Agreement between Seller and XinTec Inc., dated as of June 8, 2000; the License Agreement between Seller and Sanyo Electric Co., Ltd., dated as of March 26, 2001; the Captive License Agreement between Seller and Omnivision International Holding Ltd., dated as of May 4, 2004; and the License Agreement between Seller and China WLCSP Ltd., dated as of May 30, 2005.
Key License Agreements means, collectively, (i) the License Agreement dated December 23, 2002 by and among SCR Pharmatop S.A. and Bristol-Myers Squibb Company; (ii) the IV APAP Agreement (U.S. and Canada) dated February 21, 2006 by and between the Company and Bristol-Myers Squibb Company; (iii) the License Agreement dated November 27, 2012 by and between the Company and SCR Pharmatop S.A. and Paddock Laboratories, LLC and Perrigo Company; (iv) the Settlement Agreement dated November 27, 2012 by and between the Company and SCR Pharmatop S.A. and Paddock Laboratories, LLC and Perrigo Company; and (v) the settlement agreement and binding term sheet, each dated January 28, 2014, among the Company, Sandoz, Inc., Sandoz AG, Neogen International N.V. and APC Pharmaceuticals, LLC.